Gene: AT2G36230
Gene description
TAIR ID: AT2G36230
Short description: Aldolase-type TIM barrel family protein
Pathogen responsiveness: -0.43
General responsiveness: -1.81
GO biological process
tryptophan biosynthetic process, histidine biosynthetic process
GO cellular component
chloroplast
GO molecular function
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase activity
click to view PPI networkCoexpression network
Differentially expressed condition 
15 conditions
| Series | Control | Treatment | Log2FC | Adj. P value |
|---|---|---|---|---|
| GSE17500 | Col, 35S:AFB1, control 0 h | Col, 35S:AFB1, PstDC3000 24 h | -1.80 | 4.90E-05 |
| GSE17500 | Col, WT, control 0 h | Col, WT, PstDC3000 24 h | -1.77 | 2.82E-05 |
| GSE17500 | Col, miR393, control 0 h | Col, miR393, PstDC3000 24 h | -1.73 | 5.29E-05 |
| GSE18978 | Col, WT, control 24 h | Col, WT, PsmES4326 24 h | -2.19 | 1.71E-11 |
| GSE40544 | Col, WT, control | Col, WT, PstDC3000 EV | -1.52 | 8.11E-06 |
| GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 12 h | -2.42 | 6.23E-14 |
| GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 8 h | -1.80 | 5.75E-12 |
| GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 12 h | -2.21 | 2.44E-13 |
| GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 4 h | -1.93 | 1.99E-12 |
| GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 8 h | -2.25 | 1.57E-13 |
| GSE45214 | Col, med16, PstDC3000 AvrRpt2 0 h | Col, med16, PstDC3000 AvrRpt2 4 h | -1.94 | 4.35E-13 |
| GSE50526 | Col, WT, mock 9 h | Col, WT, A. brassicicola 9 h | -1.58 | 1.81E-03 |
| GSE5520 | Col, WT, control 10 h | Col, WT, Cor- 10 h | -1.83 | 2.26E-05 |
| GSE56094 | Col, WT, control 10 h | Col, WT, PstDC3000 10 h | -1.53 | 3.41E-10 |
| GSE9674 | Ws-4, AtMYB30 ox, control | Ws-4, AtMYB30 ox, Xanthomonas strain Xcc147 6 h | -1.62 | 4.10E-04 |
Copyright © 2017 Ziding Zhang's Lab - China Agricultural University. All Rights Reserved.